Navigation Links
Winner Medical Reports First Quarter Fiscal 2011 Results
Date:2/10/2011

The calculation of these non-GAAP measures allows the Company to compare its operating results with those of other companies without giving effect to expenses related to share-based compensation, which may vary for different companies for reasons unrelated to the overall operating performance of a company's business.

These non-GAAP measures are not measures of performance under accounting principles generally accepted in the United States (U.S. GAAP). The Company includes them in this press release in order to:

  • improve transparency for investors;

  • assist investors in their assessment of the Company's operating performance;

  • facilitate comparisons to historical performance;

  • ensure that these measures are fully understood in light of how the Company evaluates its operating results; and

  • properly define the metrics used and confirm their calculation.

  • These non-GAAP measures are not meant to be considered in isolation or as a substitute for items appearing on the Company's financial statements prepared in accordance with U.S. GAAP. Rather, the non-GAAP measures should be used as a supplement to U.S. GAAP results to assist the reader in better understanding the operational performance of the Company. The Company recognizes that the usefulness of these non-GAAP measures has certain limitations, including:

  • These non-GAAP measures do not include share-based compensation expense. Because the Company periodically has granted, and expects to continue to grant, options and restricted share awards to its employees, share-based compensation expense is a necessary element of the Company's costs and ability to generate profits and cash flows. Therefore, any measure that excludes share-based compensation expense may have material limitations.

  • The manner in which the Company calculates these non-GAAP measures may differ from that of other companies, which limits their usefulness as compa
    '/>"/>

  • SOURCE Winner Medical Group Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. Winner Medical Group Inc. to Host First Quarter 2011 Earnings Conference Call on Thursday, February 10, 2011 at 08:30 a.m. EST
    2. Winner Medical Obtains Cotton Processing Certificate from the State Development and Reform Commission
    3. Winner Medical to Participate in Arab Health 2011, International Healthcare Exhibition, in Dubai
    4. Winner Medical Honored with Shenzhen Baoan District Quality Award
    5. Winner Medical and Cotton Inc. Promote PurCotton(R) Brand and Natural(TM) Trademark in Shanghai
    6. Winner Medical Reports Fourth Quarter and Fiscal 2010 Results
    7. 2010 UCB Rheumatoid Arthritis Family Scholarship Winners Announced
    8. MedImmune Announces Winners of the 5th Annual Respiratory, Inflammation and Autoimmunity Research Abstract Competition
    9. Winner Medical Announces Preliminary Fiscal Fourth Quarter 2010 Results
    10. Next-Generation Pharmacist Winner Announced
    11. Winners Announced in 2010 Collegiate Inventors Competition®
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2014)...  The Healthcare Analytics Summit 2014 (HAS ... Salt Lake City , Sept. 24-25 has added ... organizations in the U.S. and beyond.  HAS ,14, powered ... devoted to providing immersive learning experiences on the ... accountable care initiatives and population health managemen t ...
    (Date:7/29/2014)... MOUNTAIN VIEW, Calif. , July 29, 2014 ... antivirals has amplified with rising incidence rates and ... absence of a preventative vaccine. Change is underway ... and interferon regimens towards highly effective, easily-tolerated, interferon-free ... http://photos.prnewswire.com/prnh/20140728/130662 Gilead,s mega blockbuster ...
    (Date:7/29/2014)... LONDON , July 29, 2014 ... 2014 Global Frost & Sullivan Best Practices Award ... solution is a cloud-based platform that connects digital ... - such as providers, pharmaceutical companies, prevention and ... electronics. Each year, Frost & ...
    Breaking Medicine Technology:Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 2Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 3Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 4Health Catalyst Adds Keynote Speakers, New Sessions, and Expands Attendee Limit for Healthcare Analytics Summit 2014 5A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 2A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 3A Treatment Revolution is Underway: All-Oral Therapies Transform Global Hepatitis C Antiviral Market 4Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform 2Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform 3Frost & Sullivan Commends Validic for Delivering Superior Customer Value through its mHealth Interoperability Technology Platform 4
    ... ZURICH , July 19, 2010 Today, Novo Nordisk ... designed to investigate the effects of modern insulins in,the management of type 2 diabetes.[1] ... Spanning 28 countries across ... largest observational study,in insulin therapy. , , ...
    ... July 16 Human erythropoietin (EPO) is a ... and spinal cord injury, and Parkinson,s disease. However, EPO drug ... cross the blood-brain barrier (BBB). In acute stroke or brain ... the insult when neuroprotection is still possible. Therefore, large molecule ...
    Cached Medicine Technology:World's Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients 2World's Largest Study on Insulin Therapy Completes Recruitment With 60,000 Patients 3ArmaGen® Re-engineers Erythropoietin for Brain Penetration 2
    (Date:7/29/2014)... rates rise in association with extremely hot weather. The ... 2003, for example, resulted in about 22,000 extra deaths. ... at the Institute of Epidemiology II at the Helmholtz ... the number of deaths caused by cardiovascular disease in ... temperatures in the study. , "Our findings confirm the ...
    (Date:7/29/2014)... handle stressful situations better than others, and it,s ... show differences in how they respond. , Researchers ... brains of genetically identical mice that predicts how ... , The findings, published July 29 in ... prevent potential consequences of chronic stress -- such ...
    (Date:7/29/2014)... (PRWEB) July 29, 2014 Foot Levelers ... lecturer at the Florida Chiropractic Association (FCA) National Convention ... Effects on the Kinetic Chain Changes on Thursday, August ... talk is focusing on the positive impact functional foot ... such as low back pain, plantar fasciitis, and hammertoes. ...
    (Date:7/29/2014)... Dallas, Texas (PRWEB) July 29, 2014 ... the Global Biosimilars Market report is an essential ... biosimilars industry. Using detailed company data, financial analysis, ... in-depth analysis of the current and future growth ... the various regulatory frameworks under which biosimilars are ...
    (Date:7/29/2014)... Catalent Pharma Solutions, the global leader ... for pharmaceutical, biologic, and consumer health products, today ... US Platform Leader of Pharmaceutical Softgels, will present ... Formulations using Soft Capsule Delivery Systems” at the ... of Drug Delivery Systems (30-31 July 2014, Tokyo, ...
    Breaking Medicine News(10 mins):Health News:Mortality rates increase due to extreme heat and cold 2Health News:A new brain-based marker of stress susceptibility 2Health News:Foot Levelers CEO Kent Greenawalt Speaking at FCA Convention 2Health News:World Biosimilars Market Value Exceed $262 Billion by 2019 Says a New Report Available at MarketOptimizer.org 2Health News:World Biosimilars Market Value Exceed $262 Billion by 2019 Says a New Report Available at MarketOptimizer.org 3Health News:World Biosimilars Market Value Exceed $262 Billion by 2019 Says a New Report Available at MarketOptimizer.org 4Health News:Catalent Expert to Present on Enhancing Bioavailability of Poorly Absorbed Drugs at Japan Society of Drug Delivery Systems 2
    ... of Oaks Development,Group announced today the company closed on ... 3603 Paesanos Parkway in north central,San Antonio. The ... 1604 and,Northwest Military Highway, will feature the company,s unique ... tenants, equity,investors and the developer. , ...
    ... and John Centrello decided to bank their baby,s cord blood with M.A.Z.E. ... hoping never to use it, but wanted to have it just in ... ... While pregnant, Danielle and John Centrello decided to bank their baby,s ...
    ... December 8, 2008Medical specialists at the nation,s largest professional ... have about data presented by the FDA in support ... and the potential effect of the federal agency,s analyses ... are to be conducted in the future. , It ...
    ... Unilens Vision Inc.,(OTC Bulletin Board: UVICF; TSX Venture ... specialty contact lenses,today announced the acquisition of the ... Inc. located in Michigan. , ... agreement, Unilens acquired certain assets of Aero,Contact Lens, ...
    ... chronic hepatitis C and advanced liver disease with long-term ... and liver inflammation, but the treatment did not slow ... study finds. , These findings come from the clinical ... and are reported in the Dec. 4 issue of ...
    ... Cancer Report Released by IARC; U.S. Groups List Six Critical Steps ... , ATLANTA, Dec. 9 Despite ... men and women in the United States continue to decline, cancer ... the year 2010, and low- and middle-income countries will feel the ...
    Cached Medicine News:Health News:Oaks Development Group Closes on Third San Antonio Project 2Health News:Oaks Development Group Closes on Third San Antonio Project 3Health News:Local Child Treated In Clinical Trial To Ease Symptoms of Cerebral Palsy 2Health News:Local Child Treated In Clinical Trial To Ease Symptoms of Cerebral Palsy 3Health News:Local Child Treated In Clinical Trial To Ease Symptoms of Cerebral Palsy 4Health News:Unilens Vision Acquires Aero Contact Lens, Inc. 2Health News:Hepatitis C treatment reduces the virus but liver damage continues 2Health News:Hepatitis C treatment reduces the virus but liver damage continues 3Health News:Leading U.S. Cancer Organizations Unite Against the Growing Global Cancer Burden 2Health News:Leading U.S. Cancer Organizations Unite Against the Growing Global Cancer Burden 3Health News:Leading U.S. Cancer Organizations Unite Against the Growing Global Cancer Burden 4Health News:Leading U.S. Cancer Organizations Unite Against the Growing Global Cancer Burden 5Health News:Leading U.S. Cancer Organizations Unite Against the Growing Global Cancer Burden 6
    ... The new Guidant VASOVIEW® ... to deliver a new level ... harvesting for both the saphenous ... simultaneous cut-and-seal capability, it lets ...
    ...
    ... Now rapid intrapartum or antepartum GBS results ... versus 2 days. This revolutionary in vitro diagnostic ... designed to be run in the clinical lab ... and delivery nurses 24 hours a day, ...
    ... contains primers and a FAM-labeled probe that is ... the mecA gene. In addition, this ASR contains ... an internal control sequence. This ASR requires an ... reporter dyes such as the Cepheid SmartCycler System. ...
    Medicine Products: